Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
HPRT1 encodes hypoxanthine-guanine phosphoribosyltransferase, a key enzyme in purine salvage. Hemizygous loss-of-function in males and carrier status in females leads to overproduction of uric acid, manifesting as hyperuricemia and gout with an X-linked recessive inheritance pattern.
Genetic evidence arises from nine unrelated probands (PMID:10451080,15536609,15334740,15862284,26073243,27288985,9868957,1483694,17309125) presenting with gout or hyperuricemia caused by distinct HPRT1 mutations. Variants include missense substitutions (e.g., c.152G>A (p.Arg51Gln) and c.206A>T), frameshifts and splicing defects. One representative hypomorphic allele, c.481G>T (p.Ala161Ser), was identified in a patient with severe tophaceous gout refractory to allopurinol (PMID:27288985).
Segregation analysis in a Taiwanese aboriginal pedigree demonstrated the HPRT(Tsou) variant (c.152G>A (p.Arg51Gln)) co-segregating with hyperuricemia in ten affected male and female relatives across two generations (PMID:10451080).
The variant spectrum includes six missense mutations, four novel point mutations in exon 2 or exon 3, and at least two splice-site defects. Clinical severity correlates inversely with residual enzyme activity, with partial deficiencies causing gout and near-complete loss resulting in Lesch-Nyhan syndrome.
Functional assays in erythrocytes and lymphocytes show HPRT activity reduced to 5–30% of normal in gout patients, confirming haploinsufficiency as the pathogenic mechanism and correlating with increased serum urate levels (PMID:15536609,15334740,27288985).
A regulatory defect without coding region mutation has been reported (normal HPRT coding but reduced activity), highlighting non-coding mechanisms (PMID:15862284). Overall, the evidence supports a strong X-linked recessive association between HPRT1 and gout.
Key take-home: Screening for HPRT1 variants in male patients with early-onset or refractory gout can guide diagnosis, management, and genetic counseling.
Gene–Disease AssociationStrongNine unrelated probands (PMID:10451080,15536609,15334740,15862284,26073243,27288985,9868957,1483694,17309125), segregation in ten relatives in one kindred (PMID:10451080) Genetic EvidenceStrongNine independent HPRT1 mutations in probands with gout, segregation across two generations, and variant spectrum including missense and splice defects Functional EvidenceModeratePartial HPRT enzyme activity (5–30% of normal) in patient erythrocytes and lymphocytes correlates with hyperuricemia (PMID:15536609,15334740,27288985) |